Carrie Wolinetz
Carrie Wolinetz
Senior Advisor to the Director
National Institute of Health
In office
2022–2023
Deputy Director for Health & Life Sciences
White House Office of Science and Technology Policy
In office
2021–2022
Associate Director of Science Policy
National Institutes of Health
In office
2015–2021
Personal details
Alma materCornell University, B.A.
Penn State, Ph.D.
Scientific career
InstitutionsLewis-Burke Associates
Federation of American Societies for Experimental Biology
Association of American Universities

Carrie Wolinetz (née Carrie Golash) is the Principal and Chair of Lewis-Burke Associate's Health and Bioscience Innovation Policy Practice Group. She formerly served in the National Institutes of Health as Senior Advisor to the Office of the Director, Associate Director for Science Policy, and Chief of Staff to Francis Collins. She also led the inaugural Health and Sciences division in the White House Office of Science and Technology Policy.[1][2]

Education

Wolinetz grew up in Syracuse, NY and she received her undergraduate degree in Animal Science from Cornell University, and received her Ph.D. from Penn State University in Animal Science, with a focus on reproductive physiology.[1]

Career

Wolinetz began work in 2002 at the Federation of American Societies for Experimental Biology where she served as the Director of Scientific Affairs and Public Relations.[3] Her work focused on bioethical concerns, including stem cells and biosecurity.[1] She transitioned in 2010 to the Association of American Universities, where she worked as the Deputy Vice President for Federal relations and lobbied the National Institutes of Health on biomedical policy and funding issues.[4] Wolinetz also worked as a Chair at the Association for Women in Science[1] and as President of United for Medical Research.[3]

National Institutes of Health

In 2015, Wolinetz joined the National Institutes of Health (NIH) as Associate Director for Science Policy. In that role she worked on policies concerning the ethical treatment of human subjects in clinical research.[5] She oversaw the streamlining the institutional review board policy for multisite research[6] and helped launch the NIH's data sharing policy.[7] She also oversaw programs to combat sexual harassment in the scientific field.[8]

In addition, Wolinetz led the Institute's efforts to develop better practices for dealing with emerging biotechnology. She developed regulations for dual-use biotechnology,[9] especially gain-of-function research,[10][11] and transformed the Recombinant DNA Advisory Committee (RAC) working on gene editing into the Novel and Exceptional Technology and Research Advisory committee (NExTRAC), which covered the broader field of novel biotechnology advances.[2]

White House Office of Science and Technology Policy

In 2021, Wolinetz joined the President Biden's White House in the Office of Science and Technology Policy.[12] In that role, she developed a policy to increase biotechnology and biomanufacturing in the United States,[13][14] oversaw the President's American Pandemic Preparedness plan,[2] and addressed gender and racial inequality in the scientific field.[15]

Lewis-Burke Associates

In 2023, Wolinetz joined Lewis-Burke Associates to work as the Principal and Chair for their Health and Bioscience Innovation Policy Practice Group.[1] She also teaches a course at Georgetown University on international science and technology policy.[16]

References

  1. 1 2 3 4 5 "Carrie D. Wolinetz, Ph.D." Lewis Burke. Retrieved 2023-06-02.
  2. 1 2 3 "Statement on Departure of Dr. Carrie Wolinetz". National Institutes of Health (NIH). 2023-03-29. Retrieved 2023-06-02.
  3. 1 2 "Carrie D. Wolinetz, Ph.D. | AcademyHealth". academyhealth.org. Retrieved 2023-06-02.
  4. ↑ "Appointment of Dr. Carrie Wolinetz as Associate Director for Science Policy, NIH". National Institutes of Health (NIH). 2015-03-10. Retrieved 2023-06-02.
  5. ↑ Wolinetz, Carrie D.; Tabak, Lawrence A. (2023-05-23). "Transforming Clinical Research to Meet Health Challenges". JAMA. 329 (20): 1740–1741. doi:10.1001/jama.2023.3964. ISSN 1538-3598. PMID 37115557. S2CID 258375441.
  6. ↑ Wolinetz, Carrie D.; Collins, Francis S. (2017-07-03). "Single-Minded Research Review: The Common Rule and Single IRB Policy". The American Journal of Bioethics. 17 (7): 34–36. doi:10.1080/15265161.2017.1328542. ISSN 1526-5161. PMC 6688160. PMID 28661736.
  7. ↑ Flambury, Mariela (2020-10-29). "NIH Releases New Policy for Data Management and Sharing – NIH Extramural Nexus". Retrieved 2023-06-02.
  8. ↑ Wolinetz, Carrie D.; Lauer, Michael S.; Collins, Francis S. (2020-06-19). "Combating sexual harassment". Science. 368 (6497): 1291. Bibcode:2020Sci...368.1291W. doi:10.1126/science.abd2644. ISSN 0036-8075. PMID 32527926.
  9. ↑ Wolinetz, Carrie D. (2012-06-22). "Implementing the New U.S. Dual-Use Policy". Science. 336 (6088): 1525–1527. Bibcode:2012Sci...336.1525W. doi:10.1126/science.1223995. ISSN 0036-8075. PMID 22723409. S2CID 38553763.
  10. ↑ Subbaraman, Nidhi (2020-01-27). "US officials revisit rules for disclosing risky disease experiments". Nature. doi:10.1038/d41586-020-00210-5. PMID 33495609. S2CID 213046275.
  11. ↑ "Biosecurity board grapples with how to rein in risky flu studies". www.science.org. Retrieved 2023-06-02.
  12. ↑ "The Week of November 1, 2021". www.aip.org. Retrieved 2023-06-02.
  13. ↑ Wolinetz, Carrie (2022-09-21). "How the US can harness the possibilities of biotechnology". The Hill. Retrieved 2023-06-02.
  14. ↑ House, The White (2022-09-12). "FACT SHEET: President Biden to Launch a National Biotechnology and Biomanufacturing Initiative". The White House. Retrieved 2023-06-02.
  15. ↑ Ten Hagen, Kelly G.; Wolinetz, Carrie; Clayton, Janine A.; Bernard, Marie A. (2022-03-25). "Community voices: NIH working toward inclusive excellence by promoting and supporting women in science". Nature Communications. 13 (1): 1682. Bibcode:2022NatCo..13.1682T. doi:10.1038/s41467-022-28665-2. ISSN 2041-1723. PMC 8956673. PMID 35338142.
  16. ↑ "Georgetown University Faculty Directory". gufaculty360.georgetown.edu. Retrieved 2023-06-02.
Public Domain This article incorporates public domain material from websites or documents of the National Institutes of Health.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.